Supplements Understanding Bipolar Disorder: Impact on Patients, Providers, and Empoyers
Bipolar Disorder: Disease Burden
Bipolar disorder poses a major challenge to the healthcare system. The condition is frequently misdiagnosed and may be more common than previously thought. Recurrence rates are high, even with ongoing therapy. Bipolar disorder affects many aspects of a patient's life. Loss of function is common, and quality of life is often greatly reduced. Unemployment rates are high among patients with bipolar disorder, and individuals often have difficulty in the workplace and in social and personal relationships. Individuals with bipolar disorder have high rates of psychiatric and medical comorbidity, which contributes to increased utilization of healthcare resources. The estimated annual societal cost of bipolar disorder ranges from $10 billion to $45 billion.
1. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
2. Bebbington P, Ramana R. The epidemiology of bipolar affective disorder. Soc Psychiatry Psychiatr Epidemiol. 1995;30:279-292.
3. Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996;276:293-299.
4. Hirschfeld RMA, Calabrese JR, Weissman M. Lifetime prevalence of bipolar I and II disorders in the United States. Abstract presented at: The 155th Annual Meeting of the American Psychiatric Association; May 18-23, 2002; Philadelphia, Pa.
5. Dunner DL. Clinical consequences of under-recognized bipolar spectrum disorder. Bipolar Disord. 2003;5:456-463.
6. Hendrick V, Altshuler LL, Gitlin MJ, Delrahim S, Hammen C. Gender and bipolar illness. J Clin Psychiatry. 2000;61:393-396.
7. Leibenluft E. Women with bipolar illness: clinical and research issues. Am J Psychiatry. 1996;153:163-173.
8. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic- Depressive Association (DMDA) survey of bipolar members. J Affect Disord. 1994;31:281-294.
9. Yassa R, Nair V, Nastase C, Camille Y, Belzile L. Prevalence of bipolar disorder in a psychogeriatric population. J Affect Disord. 1988;14:197-201.
10. Sajatovic M, Blow F, Ignacio RV, Kales HC. New onset bipolar disorder in later life. Am J Geriatr Psychiatry. 2005;13:282-289.
11. Gitlin MJ, Swendsen J, Heller TL, Hammen C. Relapse and impairment in bipolar disorder. Am J Psychiatry. 1995;152:1635-1640.
12. Bowden CL, Krishnan A. Pharmacotherapy for bipolar depression: an economic assessment. Expert Opin Pharmacother. 2004;5:1101-1107.
13. Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin K. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affect Disord. 1999;52:135-144.
14. Angst J, Gamma A, Lewinsohn P. The evolving epidemiology of bipolar disorder. World Psychiatry. 2002;1:146-148.
15. Baldessarini R, Tondo L, Hennen J. Treatment delays in bipolar disorders. Am J Psychiatry. 1999;156:811-812.
16. Thomas P. The many forms of bipolar disorder: a modern look at an old illness. J Affect Disord. 2004;79(suppl 1):S3-S8.
17. Bowden CL. A different depression: clinical distinctions between bipolar and unipolar depression. J Affect Disord. 2005:84:117-125.
18. Li J, McCombs JS, Stimmel GL. Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program. J Affect Disord. 2002;71:131-139.
19. Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry. 1999;156:1264-1266.
20. Ghaemi SN, Hsu DJ, Soldani F, Goodwin FK. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord. 2003;5:421-433.
21. Wehr TA, Goodwin FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry. 1979;36:555-559.
22. Wehr TA, Sack DA, Rosenthal NE, Cowdry RW. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry. 1988;145:179-184.
23. Altshuler LI, Hendrick V, Parry B. Pharmacological management of premenstrual disorder. Harv Rev Psychiatry. 1995;2:233-245.
24. Fountoulakis KN, Vieta E, Sanchez-Morno J, Kaprinis SG, Goikolea JM, Kaprinis GS. Treatment guidelines for bipolar disorder: a critical review. J Affect Disord. 2005;86:1-10.
25. McCombs JS, Thiebaud P, Shi L. Impact of unrecognized bipolar disorders in patients treated with antidepressant medications [abstract]. Value Health. 2003;6:352.
26. Murray CJ, Lopez AD. Global mortality, disability and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349:1436-1442.
27. Hirschfeld MA, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the National Depressive and Manic-Depressive Association 2000 Survey of individuals with bipolar disorder. J Clin Psychiatry. 2003;64:161-174.
28. Kupfer DJ, Frank E, Grochocinski VJ, Cluss PA, Houck PR, Stapf DA. Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J Clin Psychiatry. 2002;63:120-125.
29. Cooke RG, Robb JC, Young LT, Joffe RT. Wellbeing and functioning in patients with bipolar disorder assessed using the MOS 20-item short form (SF-20). J Affect Disord. 1996;39:93-97.
30. United States Department of Health, Education, and Welfare: Medical practice project: a state-of-the-science report for the office of the Science Secretary for the US Department of Health, Education, and Welfare. Policy Research, Baltimore, Maryland, USA, 1979.
31. Goldberg JF, Harrow M. Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up. J Affect Disord. 2004;81:123-131.
32. Dean BB, Gerner D, Gerner RH. A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder. Curr Med Res Opin. 2004;20:139-154.
33. Woods SW. The economic burden of bipolar disease. J Clin Psychiatry. 2000;61(suppl 13):38-41.
34. Chen YW, Dilsaver SC. Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other Axis I disorders. Biol Psychiatry. 1996;39:896-899.
35. Kessler RC, Borges G, Walters EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry. 1999;56:617-626.
36. Suppes T, Leverich GS, Keck PE, et al. The Stanley Foundation Bipolar Treatment Outcome Network II. Demographics and illness characteristics of the first 261 patients. J Affect Disord. 2001;67:45-59.
37. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. JAMA. 1990;264:2511-2518.
38. Chen YW, Dilsaver SC. Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area Survey. Am J Psychiatry. 1995;152:280-282. 39. Chen YW, Dilsaver SC. Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders. Psychiatry Res. 1995;59:57-64.
40. McElroy SL, Altshuler LL, Tuppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry. 2001;158:420-426.
41. McElroy SL. Diagnosing and treating comorbid (complicated) bipolar disorder. J Clin Psychiatry. 2004;65(suppl 15):35-44.
42. Comtois KA, Russo JE, Roy-Byrne P, Ries RK. Clinicians' assessment of bipolar disorder and substance abuse as predictors of suicidal behavior in acutely hospitalized psychiatric inpatients. Biol Psychiatry. 2004;56:757-763.
43. Singh J, Mattoo SK, Sharan P, Basu D. Quality of life and its correlates in patients with dual diagnosis of bipolar affective disorder and substance dependence. Bipolar Disord. 2005;7:187-191.
44. Kessing LV, Anderson PK. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? J Neurol Neurosurg Psychiatry. 2004;75:1662-1666.
45. Wyatt RJ, Henter I. An economic evaluation of manic-depressive illness—1991. Soc Psychiatry Psychiatr Epidemiol. 1995;30:213-219.
46. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of depression in 1990. J Clin Psychiatry. 1993;54:405-418.
47. Begley CE, Annegers JF, Swann AC, et al. The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. Pharmacoeconomics. 2001;19:483-495.